iSpecimen (ISPC) Return on Capital Employed (2021 - 2026)
iSpecimen (ISPC) posted quarterly Return on Capital Employed of 399.78% for Q1 2026, down 4202.0% year-over-year from 9.75% in Q1 2025, and down 35.06% quarter-over-quarter from 295.99% in Q4 2025.
iSpecimen (ISPC) Return on Capital Employed (2021 - 2026) Analysis & Trends
iSpecimen's Return on Capital Employed history runs 6 years deep, the most recent figure standing at 399.78% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 4202.0% year-over-year to 399.78%; the TTM figure through Mar 2026 stood at 399.78% (down 4202.0% YoY), while the FY2025 annual figure was 279.73%, down 9294.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 399.78%, down from 295.99% in the prior quarter.
- The five-year high for Return on Capital Employed was 22.62% in Q1 2022, with the low at 868.47% in Q2 2025.
- The 5-year median for Return on Capital Employed is 137.35% (2024), against an average of 223.31%.
- The sharpest annual moves came in 2022 and 2025: Return on Capital Employed slumped 866 bps in 2022, then plunged 70824 bps in 2025.
- iSpecimen's Return on Capital Employed stood at 46.31% in 2022, then slumped by 141 bps to 111.6% in 2023, then tumbled by 151 bps to 280.55% in 2024, then slipped by 6 bps to 295.99% in 2025, then sank by 35 bps to 399.78% in 2026.
- Business Quant data shows ISPC's Return on Capital Employed at 399.78% in Q1 2026, 295.99% in Q4 2025, and 667.35% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 8.30% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 6.42% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -13.91% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 14.57% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 10.49% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 68.60% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 17.55% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 49.80% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 8.97% |
| 10 | iSpecimen | 2.25 Mn | -2.16 Mn | 68,650.00 | -617.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -617.94% |
| Mar 31, 2026 | -399.78% |
| Dec 31, 2025 | -295.99% |
| Sep 30, 2025 | -667.35% |
| Jun 30, 2025 | -868.47% |
| Mar 31, 2025 | -357.76% |
| Dec 31, 2024 | -280.55% |
| Sep 30, 2024 | -183.61% |
| Jun 30, 2024 | -160.23% |
| Mar 31, 2024 | -137.35% |
| Dec 31, 2023 | -111.60% |
| Sep 30, 2023 | -77.82% |
| Jun 30, 2023 | -67.16% |
| Mar 31, 2023 | -53.39% |
| Dec 31, 2022 | -46.31% |
| Sep 30, 2022 | -38.12% |
| Jun 30, 2022 | -28.17% |
| Mar 31, 2022 | -22.62% |
| Dec 31, 2021 | -24.52% |
| Sep 30, 2021 | -29.46% |